Matt Ottmer has served as Chief Executive Officer and a member of the Board of Directors of Kisbee Therapeutics since April 2021. He is an accomplished and collaborative biotech leader with more than 25 years of experience advancing scientific innovations into life changing therapeutics.
Previously, he served as Chief Operating Officer at Voyager Therapeutics and Momenta Therapeutics, where he oversaw Research, Development, Manufacturing, Program & Alliance Management, and Commercial activities. Prior to joining Momenta, he spent 16 years at Biogen in a range of roles, including Senior Vice President Strategy & Emerging Business, Head of Tysabri Business, Chief of Staff to the CEO, President and General Manager Biogen Idec Hemophilia, and Vice President Global Operations. Before his time at Biogen, Matt worked at A.T. Kearney as a management consultant serving clients across North America and Europe spanning the medical device, technology services, and various manufacturing industries.
In addition to his work in Life Sciences, Matt is deeply committed to public education and serves on the Board of Trustees of Excel Academy Charter Schools and NextGen Talent. Matt earned his MBA from the Kellogg School of Management at Northwestern University and a B.A. from the University of Michigan.